(Q42166967)

English

Electrochemiluminescence assay for basic carboxypeptidases: inhibition of basic carboxypeptidases and activation of thrombin-activatable fibrinolysis inhibitor

scientific article published on August 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Electrochemiluminescence assay for basic carboxypeptidases: inhibition of basic carboxypeptidases and activation of thrombin-activatable fibrinolysis inhibitor (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

author name string

Shi-Shan Mao

1

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Dennis Colussi

2

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Carolyn M Bailey

3

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Michele Bosserman

4

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Christine Burlein

5

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Stephen J Gardell

6

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Steven S Carroll

7

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

language of work or name

0 references

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Analytical Biochemistry

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

319

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

159-170

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Carboxypeptidases from A to z: implications in embryonic development and Wnt binding

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Basic carboxypeptidases: regulators of peptide hormone activity

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Peptides, enzymes and obesity: new insights from a 'dead' enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Bradykinin-Degrading Enzymes: Structure, Function, Distribution, and Potential Roles in Cardiovascular Pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Cloning and expression of human carboxypeptidase Z, a novel metallocarboxypeptidase

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Thrombin activable fibrinolysis inhibitor (TAFI): molecular genetics of an emerging potential risk factor for thrombotic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Purification and characterization of a new arginine carboxypeptidase in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Characterization of plasmin-mediated activation of plasma procarboxypeptidase B. Modulation by glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Plasmin-mediated activation and inactivation of thrombin-activatable fibrinolysis inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Fast homogeneous assay for plasma procarboxypeptidase U.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

An improved spectrophotometric assay for human plasma carboxypeptidase N1

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Anisylazoformylarginine: a superior assay substrate for carboxypeptidase B type enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Human carboxypeptidase M

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Purification and characterization of human metallocarboxypeptidase Z.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Electrochemiluminescence: a new diagnostic and research tool. ECL detection technology promises scientists new "yardsticks" for quantification

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

A potent mercapto bi-product analogue inhibitor for human carboxypeptidase N

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

A simplified method for cyanogen bromide activation of agarose for affinity chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Affinity chromatography of pancreatic carboxypeptidases using a carboxypeptidase inhibitor from potatoes as ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Development of a novel helicase assay using electrochemiluminescence

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Homogeneous assays for single-nucleotide polymorphism typing using AlphaScreen

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Protamine inhibits plasma carboxypeptidase N, the inactivator of anaphylatoxins and kinins

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

PDZ domains: structural modules for protein complex assembly

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

A PDZ domain-based detection system for enzymatic assays

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Carboxypeptidase R is an inactivator of complement-derived inflammatory peptides and an inhibitor of fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

High levels of coagulation factor XI as a risk factor for venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Total thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and pro-TAFI in patients with haemophilia A.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Activation and characterization of procarboxypeptidase B from human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2803%2900252-5

7 January 2021

Identifiers

10.1016/S0003-2697(03)00252-5

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42166967&oldid=1935095762"